[Actual aspects of therapy with beta-adrenergic stimulants (author's transl)].
D000318:Adrenergic beta-Agonists / Q000009:adverse effects / Q000627:therapeutic use*; D000403:Airway Resistance / Q000187:drug effects; D001249:Asthma / Q000188:drug therapy; D001991:Bronchitis / Q000188:drug therapy; D002923:Cilia / Q000187:drug effects; D000242:Cyclic AMP / Q000096:biosynthesis; D003550:Cystic Fibrosis / Q000188:drug therapy; D004357:Drug Synergism; D005938:Glucocorticoids / Q000627:therapeutic use; D006323:Heart Arrest / Q000188:drug therapy; D006801:Humans; D006935:Hypercapnia / Q000378:metabolism; D006973:Hypertension / Q000188:drug therapy; D006980:Hyperthyroidism / Q000378:metabolism; D007022:Hypotension / Q000139:chemically induced; D007037:Hypothyroidism / Q000378:metabolism; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use; D010101:Oxygen Consumption / Q000187:drug effects; D010726:Phosphodiesterase Inhibitors; D011663:Pulmonary Surfactants; D013189:SRS-A / Q000037:antagonists & inhibitors; D012770:Shock, Cardiogenic / Q000188:drug therapy; D014202:Tremor / Q000139:chemically induced
D000318:Adrenergic beta-Agonists; D005938:Glucocorticoids; D008996:Monoamine Oxidase Inhibitors; D010726:Phosphodiesterase Inhibitors; D011663:Pulmonary Surfactants; D013189:SRS-A; D000242:Cyclic AMP
Aspects actuels dans la thérapie avec bêta-stimulants.